BioLife Solutions BLFS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $99.77M+5.8% | $94.33M+4.1% | $90.65M+8.0% | $83.97M+7.3% | $78.27M+4.9% | ||
| —— | —— | —— | —— | $25.67M+4.5% | ||
| —— | —— | —— | —— | $52.37M+4.5% | ||
| $8.78M+16.0% | $7.57M— | —— | —— | —— | ||
| $9.78M+0.9% | $9.7M+4.6% | $9.27M+0.2% | $9.25M+2.8% | $9M+0.8% | ||
| $46.23M+1.9% | $45.37M-2.2% | $46.41M+6.3% | $43.66M+5.0% | $41.58M+2.3% | ||
| $1.75M+1.1% | $1.73M-28.0% | $2.41M+0.7% | $2.39M+1.1% | $2.37M-20.8% | ||
| $87.69M+2.5% | $85.52M— | —— | —— | —— | ||
| -$16.71M+3.1% | -$17.23M— | —— | —— | —— | ||
| -16.7%+1.5pp | -18.3%— | —— | —— | —— | ||
| $3.07M+13.2% | $2.71M+50.1% | $1.8M+69.2% | $1.07M+1,770% | $57K+107% | ||
| $4.96M+9.7% | $4.52M+85.8% | $2.43M+61.3% | $1.51M+141% | -$3.68M+15.4% | ||
| —— | —— | -$14.72M+7.8% | -$15.98M-174% | -$5.83M+37.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $7.54M+10.5% | $6.82M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| 194.4M+0.5% | 193.5M+1.4% | 191M+1.4% | 188.4M+1.0% | 186.6M+1.6% | ||
| 191.9M+0.7% | 190.6M+0.9% | 188.9M+0.9% | 187.2M+1.0% | 185.4M+0.9% | ||
| $3.07M+13.2% | $2.71M+50.1% | $1.8M+69.2% | $1.07M+1,770% | $57K+107% | ||
| —— | —— | -$0.31+6.1% | -$0.33-175% | -$0.12+40.0% | ||
| —— | —— | -$0.31+6.1% | -$0.33-175% | -$0.12+40.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$14.95M+6.8% | -$16.04M-178% | -$5.76M+37.6% | ||
| $1.89M+4.4% | $1.81M+187% | $632K+42.0% | $445K+29.4% | $344K-30.6% | ||
| -$16.71M+3.1% | -$17.23M+0.4% | -$17.3M+1.9% | -$17.63M-669% | -$2.29M+54.9% | ||
| -$14.76M+1.5% | -$14.98M-4.2% | -$14.37M-3.2% | -$13.93M-738% | $2.18M+3,020% | ||
| -$14.76M+1.5% | -$14.98M-4.2% | -$14.37M-3.2% | -$13.93M-738% | $2.18M+3,020% | ||
| -14.8%+1.1pp | -15.9%0.0pp | -15.9%+0.7pp | -16.6%-19.4pp | 2.8%+2.7pp | ||
| -$16.71M+3.1% | -$17.23M+0.4% | -$17.3M+1.9% | -$17.63M-669% | -$2.29M+54.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioLife Solutions's revenue?
- BioLife Solutions (BLFS) generated $99.8M in revenue over the trailing twelve months, up 27.5% year over year.
- Is BioLife Solutions profitable?
- BioLife Solutions is not currently profitable: it reported a net loss of $14.5M over the trailing twelve months, a -68.7% net margin.
- What are BioLife Solutions's profit margins?
- Gross margin is 66.9% and operating margin is -16.7%, with a -68.7% net margin.
- What is BioLife Solutions's earnings per share?
- BioLife Solutions's diluted EPS over the trailing twelve months is $-0.30.
- Where does BioLife Solutions's income statement data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
